Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Bristol-Myers Squibb
(NY:
BMY
)
48.43
-0.75 (-1.53%)
Streaming Delayed Price
Updated: 2:31 PM EST, Dec 2, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
6,135,277
Open
48.95
Bid (Size)
48.42 (1,300)
Ask (Size)
48.43 (300)
Prev. Close
49.18
Today's Range
48.33 - 49.18
52wk Range
42.52 - 63.33
Shares Outstanding
2,222,113,553
Dividend Yield
5.12%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Amazon Unleashes AI Frontier Agents: A New Era of Autonomous Digital Workers
Today 14:33 EST
Amazon (NASDAQ: AMZN) has unveiled a groundbreaking class of AI agents, dubbed "frontier agents," capable of operating autonomously for extended periods—even days—without constant human intervention....
Via
TokenRing AI
Topics
Artificial Intelligence
Economy
Chronic Rare Diseases in an Aging America: Why HyBryte and Federal Policy Matter Now
Today 9:05 EST
Via
Investor Brand Network
Topics
Government
Performance
YTD
-14.7%
-14.7%
1 Month
+5.2%
+5.2%
3 Month
+2.2%
+2.2%
6 Month
-0.7%
-0.7%
1 Year
-19.2%
-19.2%
More News
Read More
Bristol-Myers Squibb Co (NYSE:BMY) Presents a Compelling Value Investment Case
↗
Today 6:32 EST
Via
Chartmill
Big Pharma Layoff Wave Extends Into Next Year: UNH, Merck, BMS, Novartis File New WARN Notices
↗
November 20, 2025
Via
Stocktwits
Topics
Workforce
Chronic Rare Diseases in an Aging America: Why HyBryte and Federal Policy Matter Now
Today 8:30 EST
From
BioMedWire
Via
GlobeNewswire
Bristol Myers Squibb Data at ASH 2025 Showcase Potential of Hematology Pipeline and Build Momentum for Next Generation Portfolio
December 01, 2025
From
Bristol Myers Squibb
Via
Business Wire
2 Undervalued, High-Quality Companies to Buy Now and Hold Forever
↗
November 30, 2025
Via
The Motley Fool
Topics
Intellectual Property
2 Top Dividend Stocks to Buy and Hold
↗
November 30, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
Intellectual Property
Should You Buy Bristol Myers Stock for Its 5.4%-Yielding Dividend?
↗
November 29, 2025
Via
The Motley Fool
Topics
Intellectual Property
Stocks
Bristol-Myers (BMY) Earnings Call Transcript
↗
November 27, 2025
Via
The Motley Fool
Topics
Earnings
BRISTOL-MYERS SQUIBB CO (NYSE:BMY) Offers a Compelling Mix of High Yield and Financial Strength for Dividend Investors
↗
November 27, 2025
Via
Chartmill
Bristol Myers Squibb to Participate in Citi’s 2025 Global Healthcare Conference
November 26, 2025
From
Bristol Myers Squibb
Via
Business Wire
Bristol Myers Squibb Receives Approval from the European Commission to Expand Use of CAR T Cell Therapy Breyanzi for Relapsed or Refractory Mantle Cell Lymphoma
November 24, 2025
From
Bristol Myers Squibb
Via
Business Wire
PacBio, Bristol-Myers Squibb, Oscar Health, Centene, and Molina Healthcare Shares Are Soaring, What You Need To Know
November 24, 2025
Via
StockStory
Topics
Economy
Monday's session: gap up and gap down stock in the S&P500 index
↗
November 24, 2025
Via
Chartmill
Which S&P500 stocks are moving before the opening bell on Monday?
↗
November 24, 2025
Via
Chartmill
Bristol Myers Squibb to Host Hematology-Focused Investor Event
November 24, 2025
From
Bristol Myers Squibb
Via
Business Wire
What's Driving the Market Sentiment Around Bristol-Myers Squibb Co?
↗
November 20, 2025
Via
Benzinga
Why GRAIL Stock Could Be Biotech’s Next Big Breakout
↗
November 19, 2025
Via
MarketBeat
Market Movers in Motion: Merck & Co. and Amer Sports Chart Volatile Courses
November 18, 2025
Via
MarketMinute
Topics
Economy
Initial Public Offering
Intellectual Property
Bristol Myers Squibb Announces Accepted Amounts and Pricing Terms of its Tender Offers
November 18, 2025
From
Bristol Myers Squibb
Via
Business Wire
Spotting Winners: Bristol-Myers Squibb (NYSE:BMY) And Branded Pharmaceuticals Stocks In Q3
November 17, 2025
Via
StockStory
Topics
Artificial Intelligence
Intellectual Property
Bristol Myers Squibb Announces Early Participation Results, Amendment and Early Settlement of Tender Offers
November 17, 2025
From
Bristol Myers Squibb
Via
Business Wire
1 Cash-Producing Stock to Keep an Eye On and 2 We Find Risky
November 16, 2025
Via
StockStory
These 2 Dividend ETFs Are a Retiree's Best Friend
↗
November 16, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
Bonds
ETFs
Frequently Asked Questions
Is Bristol-Myers Squibb publicly traded?
Yes, Bristol-Myers Squibb is publicly traded.
What exchange does Bristol-Myers Squibb trade on?
Bristol-Myers Squibb trades on the New York Stock Exchange
What is the ticker symbol for Bristol-Myers Squibb?
The ticker symbol for Bristol-Myers Squibb is BMY on the New York Stock Exchange
What is the current price of Bristol-Myers Squibb?
The current price of Bristol-Myers Squibb is 48.43
When was Bristol-Myers Squibb last traded?
The last trade of Bristol-Myers Squibb was at 12/02/25 02:31 PM ET
What is the market capitalization of Bristol-Myers Squibb?
The market capitalization of Bristol-Myers Squibb is 107.62B
How many shares of Bristol-Myers Squibb are outstanding?
Bristol-Myers Squibb has 108B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.